Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate!

Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate!

This review provides an overview of 50 years of basic and clinical research on an oncolytic avian virus, Newcastle Disease Virus (NDV), which has particular anti-neoplastic and immune stimulatory properties. Of special interest is the fact that this biological agent induces immunogenic cell death an...

Full description

Bibliographic Details
Main Author:	Volker Schirrmacher
Format:	Article
Language:	English
Published:	MDPI AG 2016-07-01
Series:	Biomedicines
Subjects:	oncolysis immunogenic cell death dendritic cells tumor vaccine immune activation virotherapy immunotherapy
Online Access:	http://www.mdpi.com/2227-9059/4/3/16

Similar Items

Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
by: Volker Schirrmacher, et al.
Published: (2019-08-01)

Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus
by: Gabriel Scheubeck, et al.
Published: (2019-07-01)

Exploiting the immunogenic potential of cancer cells for improved dendritic cell vaccines
by: Lien eVandenberk, et al.
Published: (2016-01-01)

Combined p14ARF and Interferon-β Gene Transfer to the Human Melanoma Cell Line SK-MEL-147 Promotes Oncolysis and Immune Activation
by: Otto Luiz Dutra Cerqueira, et al.
Published: (2020-10-01)

Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
by: Dobrin D. Draganov, et al.
Published: (2019-03-01)

Oncolytic virotherapy
by: Daniel Cervantes-García;, et al.
Published: (2008-01-01)

Tumor lysis with LTX-401 creates anticancer immunity
by: Wei Xie, et al.
Published: (2019-07-01)

Hitting the Target but Missing the Point: Recent Progress towards Adenovirus-Based Precision Virotherapies
by: Tabitha G. Cunliffe, et al.
Published: (2020-11-01)

Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
by: Bin Zhang, et al.
Published: (2020-11-01)

Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
by: Philippe Fournier, et al.
Published: (2013-07-01)

Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus
by: Volker Schirrmacher
Published: (2022-02-01)

A combination of genetically engineered oncolytic virus and melittin-CpG for cancer viro-chemo-immunotherapy
by: Amirhossein Bahreyni, et al.
Published: (2023-05-01)

Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma
by: Kristian M. Hargadon
Published: (2017-11-01)

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
by: Volker Schirrmacher, et al.
Published: (2022-10-01)

STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells
by: Xiaoyan Shao, et al.
Published: (2019-05-01)

Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
by: María Julia Lamberti, et al.
Published: (2020-03-01)

Advances in technology and applications of nanoimmunotherapy for cancer
by: Lei Dou, et al.
Published: (2021-08-01)

VESICULOVIRUSES AS A TOOL OF BIOTECHNOLOGY
by: L.P. Buchatskyi, et al.
Published: (2023-08-01)

Antitumor Virotherapy by Attenuated Measles Virus (MV)
by: Jean-François Fonteneau, et al.
Published: (2013-03-01)

Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy
by: Yichen Guo, et al.
Published: (2023-08-01)

The Oncolytic Virus dl922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth
by: Sarah Di Somma, et al.
Published: (2019-07-01)

New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection
by: Volker Schirrmacher
Published: (2020-03-01)

Multimodal cancer therapy involving oncolytic Newcastle Disease Virus, autologous immune cells and bispecific antibodies
by: Volker eSchirrmacher, et al.
Published: (2014-09-01)

Therapeutic implications of immunogenic cell death in human cancer
by: Fabio ePalombo, et al.
Published: (2014-01-01)

Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets
by: Graziela Gorete Romagnoli, et al.
Published: (2015-01-01)

In vitro Characterization of Enhanced Human Immune Responses by GM-CSF Encoding HSV-1-Induced Melanoma Cells
by: Delic M, et al.
Published: (2022-10-01)

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
by: Riccardo Dolcetti, et al.
Published: (2020-03-01)

Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer
by: Masakazu Hamada, et al.
Published: (2020-09-01)

Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies
by: Wuyin Wang, et al.
Published: (2022-07-01)

Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy
by: Olga V. Matveeva, et al.
Published: (2020-12-01)

Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancer
by: Seyedeh-Raheleh Niavarani, et al.
Published: (2023-02-01)

A new personalized vaccine strategy based on inducing the pyroptosis of tumor cells in vivo by transgenic expression of a truncated GSDMD N-terminus
by: Jinrong He, et al.
Published: (2022-09-01)

Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy
by: Brianne Cruickshank, et al.
Published: (2018-04-01)

Highly triple-effective synergy based on tetrahedral DNA nanostructure-induced tumor vaccines for cancer therapy
by: Jianqin Yan, et al.
Published: (2023-02-01)

Harnessing the Immunological Effects of Radiation to Improve Immunotherapies in Cancer
by: Gary Hannon, et al.
Published: (2023-04-01)

Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy
by: Zhicheng Jin, et al.
Published: (2022-10-01)

Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
by: Fang Huang, et al.
Published: (2022-07-01)

Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy
by: Jiayi Ye, et al.
Published: (2022-06-01)

Modulation of APC function and anti-tumor immunity by anti-cancer drugs
by: Kea eMartin, et al.
Published: (2015-09-01)

Therapeutic strategies to enhance immune response induced by multiple myeloma cells
by: Zhaoyun Liu, et al.
Published: (2023-05-01)